Fidelity Investments
MYOV

Fidelity Investments’s Myovant Sciences Ltd. MYOV Stock Holding History

Fidelity Investments’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,799
Closed -$75.5K – 5630
2022
Q4 		$75.5K Buy
2,799
+21
+0.8% +$552 ﹤0.01% 3306
2022
Q3 		$50K Sell
2,778
-33
-1% -$527 ﹤0.01% 3492
2022
Q2 		$35K Buy
2,811
+20
+0.7% +$221 ﹤0.01% 3698
2022
Q1 		$37K Sell
2,791
-9,058
-76% -$121K ﹤0.01% 3791
2021
Q4 		$185K Sell
11,849
-19,952
-63% -$381K ﹤0.01% 2969
2021
Q3 		$714K Sell
31,801
-78,753
-71% -$1.73M ﹤0.01% 2740
2021
Q2 		$2.52M Sell
110,554
-86,623
-44% -$1.82M ﹤0.01% 2504
2021
Q1 		$4.06M Sell
197,177
-37,758
-16% -$860K ﹤0.01% 2315
2020
Q4 		$6.49M Sell
234,935
-1,333,834
-85% -$26M ﹤0.01% 2111
2020
Q3 		$22M Sell
1,568,769
-1,312,371
-46% -$24.4M ﹤0.01% 1518
2020
Q2 		$59.4M Buy
2,881,140
+2,227,134
+341% +$30.3M 0.01% 1092
2020
Q1 		$4.94M Hold
654,006
– – ﹤0.01% 1943
2019
Q4 		$10.2M Buy
+654,006
New +$6.59M ﹤0.01% 1843

Other funds holding MYOV

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Fidelity Investments's MYOV Position: Q1 2023 in Review

Fidelity Investments sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 2,799 shares — an estimated $75.5K sold.

Fidelity Investments first reported a position in MYOV in Q4 2019 and held it in 13 quarters. The position peaked at $59.4M in Q2 2020. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

  • Fidelity Investments reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
  • Fidelity Investments sold 2,799 Myovant Sciences Ltd. shares in Q1 2023, an estimated $75.5K.
  • Fidelity Investments first reported a position in Myovant Sciences Ltd. in Q4 2019 and held it in 13 quarters.
  • Fidelity Investments's Myovant Sciences Ltd. position peaked at $59.4M in Q2 2020.
  • 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Fidelity Investments's 13F filing for Q1 2023, filed 11 May 2023.